Over the past month I’ve attended and presented at a couple of conferences.
The first was Partnerships in Clinical Trials, a gather of 1000+ professionals involved in clinical research. The second was the Evolution Summit. (I’ve included my presentations at both below).
It was great to see a number of leaders I’ve come to know and respect including Craig Lipset of Pfizer, Tomasz Sablinski of TLC, and Deirdre BeVard of Endo. To me, conferences are more about making and growing relationships than they are about specific content. That said, the highlight of the Partnerships conference for me was a presentation by Eric Topol on disruptive changes in medicine and how this will impact drug development. More…
Thanks to Moore’s law, the cost per Human Genome is falling rapidly.
Photo Credit: 